Developers of a genetic-susceptibility test for ovarian cancer might have jumped the gun, according to an OCRF-funded research consortium that found no association between a KRAS mutation and risk of the cancer.
Cancer recurrence and death occurred significantly more often in ovarian cancer patients treated with erythropoietin-stimulating agents (ESAs), data from a retrospective cohort review showed.
Almost half of patients with heavily pretreated ovarian cancer benefited from an investigational PARP inhibitor, results of a phase I study showed.
Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results of a small study reported here.
Most older patients with ovarian cancer may receive care that doesn't measure up to national standards, according to an analysis of a National Cancer Institute (NCI) database and Medicare claims data.
12/21/2010 Available ovarian cancer screening only slightly reduces the number of deaths from the disease, a new study finds. Until more sensitive screening tests can be developed, other strategies, such … Continued
11/08/2010 OCRF Grantee Lin Zhang, MD Research has provided strong support for the ovarian cancer stem cell hypothesis, which proposes that a rare subpopulation of tumor cells—cancer stem cells– have the … Continued
09/28/2010 View a seven-part series about ovarian cancer, brought to you by the Ovarian Cancer Research Fund.The series is narrated by Douglas A. Levine, MD, of Memorial Sloan-Kettering Cancer … Continued
Some of you may have recently seen articles in the newspaper or on TV about a test called OVA1. OVA1 is a test approved by the FDA which measures the … Continued
01/29/2010 Each year, OCRF awards millions of dollars in grants to researchers who are working to beat ovarian cancer. Our two newest grantees, Dr. Lin Zhang and Dr. Kathryn Terry, … Continued
06/08/2009 Last weekend a European study regarding the use of CA 125 testing in ovarian cancer patients was presented at the American Society of Clinical Oncologists (ASCO) Annual Meeting. The … Continued
03/17/2009 Today, the Ovarian Cancer Research Fund (OCRF) announced its most recent research grant recipients. Grants were awarded in three different categories: the Program Project Development Grant, the Liz Tilberis … Continued
Get email updates about research news, action alerts, and ways to join the fight.
